Crystalline forms of a 2-thiazolyl4-quinolinyl-oxy derivative, a potent HCV inhibitor

Details for Australian Patent Application No. 2009293494 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Berkenbusch, Thilo; Busacca, Carl Alan; Jaeger, Burkhard; Varsolona, Richard J.

Agent Spruson & Ferguson

Pub. Number AU-A-2009293494

PCT Pub. Number WO2010/033444

Priority 61/150,826 09.03.09 US; 61/097,291 16.09.08 US

Filing date 14 September 2009

Wipo publication date 25 March 2010

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/033444 Priority application(s): WO2010/033444

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293506-Knitted electrode assembly and integrated connector for an active implantable medical device

2009293493-Combination of HCV NS3 protease inhibitor with interferon and ribavirin